Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy

Cancer Immunology, Immunotherapy : CII
Michael FriedrichBarbara Seliger

Abstract

Immunotherapy aims to activate the immune system to fight cancer in a very specific and targeted manner. Despite the success of different immunotherapeutic strategies, in particular antibodies directed against checkpoints as well as adoptive T-cell therapy, the response of patients is limited in different types of cancers. This attributes to escape of the tumor from immune surveillance and development of acquired resistances during therapy. In this review, the different evasion and resistance mechanisms that limit the efficacy of immunotherapies targeting tumor-associated antigens presented by major histocompatibility complex molecules on the surface of the malignant cells are summarized. Overcoming these escape mechanisms is a great challenge, but might lead to a better clinical outcome of patients and is therefore currently a major focus of research.

References

Feb 1, 1993·Current Opinion in Immunology·J P Ting, A S Baldwin
Jun 26, 1997·Nature·R StarrD J Hilton
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·D H KaplanR D Schreiber
Jun 24, 1998·The Journal of Clinical Investigation·D J HicklinS Ferrone
Jul 31, 1998·Immunogenetics·P J van den ElsenA Peijnenburg
Mar 27, 1999·Seminars in Cancer Biology·S J Gobin, P J van den Elsen
May 4, 1999·International Journal of Cancer. Journal International Du Cancer·L M RealF Garrido
Feb 24, 2001·American Journal of Reproductive Immunology : AJRI·B DaviesA King
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S J GobinP J van den Elsen
Oct 26, 2001·Journal of Molecular Evolution·J K KulskiH Inoko
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Ralf GeertsenReinhard Dummer
Jul 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Micha DrukkerNissim Benvenisty
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Catherine MenierNathalie Rouas-Freiss
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Philippe MoreauEdgardo D Carosella
Apr 19, 2003·Leukemia Research·Katarína PolákováGustáv Russ
Oct 4, 2003·Journal of Leukocyte Biology·Kate SchroderDavid A Hume
Jan 8, 2004·Seminars in Cancer Biology·Chien-Chung Chang, Soldano Ferrone
Jan 22, 2004·Current Opinion in Immunology·Peter J van den ElsenNienke van der Stoep
Aug 4, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shang-mian YieXin-mei Lin
Sep 12, 2007·American Journal of Human Genetics·Zheng TanCarole Ober
Nov 30, 2007·Cancer Immunology, Immunotherapy : CII·A Nazmul H KhanThomas B Tomasi
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liz Y HanAnil K Sood
Aug 30, 2008·Tissue Antigens·K DunkerB Seliger
Dec 3, 2008·Cancer Research·A Francesca SetiadiWilfred A Jefferies
Dec 6, 2008·Advances in Cancer Research·Barbara SeligerFederico Garrido
Dec 17, 2008·Cancer Research·Christian V RecktenwaldBarbara Seliger
May 1, 2009·Journal of Immunotoxicology·Barbara Seliger
Sep 18, 2009·Annals of the New York Academy of Sciences·Tjadine M HollingPeter J van den Elsen
Nov 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sébastien FlajolletPhilippe Moreau
Mar 4, 2010·International Journal of Cancer. Journal International Du Cancer·Matthias KloorMagnus von Knebel Doeberitz
Jul 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Torsten B MeissnerKoichi S Kobayashi
Jul 29, 2010·The Journal of Biological Chemistry·Juergen BukurBarbara Seliger

❮ Previous
Next ❯

Citations

Jul 4, 2020·Journal for Immunotherapy of Cancer·Simon Jasinski-BergnerBarbara Seliger
Oct 9, 2019·International Journal of Molecular Sciences·Andrea BiancoRaffaele De Palma
Aug 21, 2020·Nature Reviews. Immunology·Devin DershJonathan W Yewdell
Mar 19, 2020·Cellular Microbiology·Jesús Osuna-PérezEsteban Veiga
Jul 29, 2020·International Journal of Molecular Sciences·Simon Jasinski-BergnerBarbara Seliger
Sep 7, 2019·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·Nataša MihailovicNicole Eter
Aug 23, 2020·Journal of Clinical Medicine·Maria-Filothei LazaridouBarbara Seliger
Oct 5, 2020·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lisa A FriedmanAnne M Mills
Oct 1, 2020·Experimental Dermatology·Carsten WeishauptKarin Loser
Nov 17, 2020·Frontiers in Molecular Biosciences·Lei WuGuihai Zhang
Mar 27, 2021·Journal of Food Biochemistry·Ivan Chan-Zapata, Maira Rubí Segura-Campos
Mar 20, 2021·The American Journal of Surgical Pathology·Anna C DusenberyAnne M Mills
May 28, 2021·Biomarker Research·Shujie ZhouJinming Yu
Jun 4, 2021·Molecular Immunology·M L M JongsmaR M Spaapen
Jun 10, 2021·Oncoimmunology·Annat RaiterRinat Yerushalmi
Jul 17, 2021·Journal of Cellular and Molecular Medicine·Yibei WangYun Han
Dec 17, 2020·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Taylor M JenkinsAnne M Mills

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.